# Memo Therapeutics: Biotechnology, Schlieren, Switzerland

> Memo Therapeutics: Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis. Based in Schlieren, Switzerland.

Source: https://millionrounds.com/startup/memo-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Biotechnology startup](https://millionrounds.com/companies)

# Memo Therapeutics

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

Funding reported Last round: Series C

Biotechnology Schlieren, Switzerland

Company summary

- **Founded:** 2012 14 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** 108.8M as listed, currency not stated
- **Last round:** Series C May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Memo Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Memo Therapeutics raised

Funding, as reported

Reported in all **108.8M** in the source's currency

Rounds **7**

Last round **Series C**

Last round date **May 2024**

Investors listed **18**

## Founders and team

From Memo Therapeutics's own website: 8 on the team.

- **Erik van den Berg** CEO, Board Member
- **Lars Spenger** CFO
- **Alex Bastian** VP Commercial Strategy
- **Kristie Clemmer** VP Clinical Operations
- **Matthieu Delincé** VP Technology
- **Ellen Rietmann Ahl** Non-Executive Director
- **Lisanne van Kouterik** General Counsel
- **Michael Cordes** Senior Director Quality Management

## On 4 portfolio pages

Investors who name them

- [Adjuvant Capital](https://millionrounds.com/fund/adjuvant-capital)
- [KurmaPartners](https://millionrounds.com/fund/kurmapartners)
- [Pureos Bioventures](https://millionrounds.com/fund/pureos-bioventures)
- [JFG Life Sciences Foundation](https://millionrounds.com/fund/jfg-life-sciences-foundation)

Each firm lists Memo Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in Switzerland

Startups like it

- [**Idorsia** Allschwil · founded 2017](https://millionrounds.com/startup/idorsia)
- [**MoonLake Immunotherapeutics** Zug · founded 2021](https://millionrounds.com/startup/moonlake-immunotherapeutics)
- [**VectivBio** Basel · founded 2019](https://millionrounds.com/startup/vectivbio)
- [**Monte Rosa Therapeutics** Basel · founded 2018](https://millionrounds.com/startup/monte-rosa-therapeutics)
- [**MindMaze** Lausanne · founded 2012](https://millionrounds.com/startup/mindmaze)
- [**SixPeaks Bio** Basel · founded 2022](https://millionrounds.com/startup/sixpeaks-bio)
- [**ESBATech** Schlieren-Zurich · founded 1998](https://millionrounds.com/startup/esbatech)
- [**CorFlow Therapeutics AG** Baar · founded 2016](https://millionrounds.com/startup/corflow-therapeutics-ag-2)

## Is this your company?

Add your raise, your deck and your story, and put Memo Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)